Clinical Trials Logo
  1. Home
  2. Other
  3. NCT06231797

AI-ECG Screening for Left Ventricular Systolic Dysfunction

Left Ventricular Systolic Dysfunction Clinical Trial

Official title:
AI-ECG Screening for Left Ventricular Systolic Dysfunction: A Prospective, Observational, Multicenter Study

Clinical Trial Summary

The purpose of the current study is to verify the effectiveness of the artificial intelligence algorithm applied to the electrocardiogram as a potential screening tool for left ventricular systolic dysfunction.

Clinical Trial Description

The current investigators have developed an artificial intelligence (AI) algorithm based on 12-lead electrocardiogram (ECG) detecting left ventricular systolic dysfunction, through 364,845 ECGs from 148,547 patients. Then, when the model was tested retrospectively on 59,805 ECGs of 24,376 patients, the model performance expressed as an area under the receiver operating characteristic curve was 0.889 (95% CI 0.887-0.891). The investigators are planning to prospectively validate the model's effectiveness as a potential screening tool for left ventricular systolic dysfunction. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT06231797
Study type Observational
Source Seoul National University Hospital
Contact Hak Seung Lee, MD
Phone +1-771-216-0764
Email cardiolee@gmail.com
Status Not yet recruiting
Phase
Start date February 1, 2024
Completion date July 10, 2025
View Details
See also
  Status Clinical Trial Phase
Active, not recruiting NCT01058837 - SCD-HeFT 10 Year Follow-up N/A
Completed NCT00752752 - The Acute Cardiovascular Effects of Marathon Running Using Magnetic Resonance Imaging N/A
Recruiting NCT04166331 - Adjunctive DobutAmine in sePtic Cardiomyopathy With Tissue Hypoperfusion Phase 3
Active, not recruiting NCT05764109 - Adherence to Cied Implantation Guidelines and Cardiac Rehabilitation
Completed NCT05630170 - The SMART-LV Pilot Study N/A
Terminated NCT01969890 - STem cElls Mobilization in Acute Myocardial Infarction Outcome Trial Phase 3
Recruiting NCT01747187 - Cardiac Stress in Septic Shock - Biomarkers, Echocardiography and Outcome N/A
Completed NCT01162083 - Identifying an Ideal Cardiopulmonary Exercise Test Parameter N/A
Completed NCT04221763 - Mechanisms and Innovations in Cardiac Resynchronisation Therapy N/A
Recruiting NCT06221891 - Early Evaluation of Left Ventricular Systolic Function Impairment in Patients With Chronic Kidney Disease by Multimodal Ultrasonography
Completed NCT04231331 - Ertugliflozin for Functional Mitral Regurgitation Phase 3
Completed NCT01500759 - Sleep-Disordered Breathing in Heart Failure - The SchlaHF-Registry
Recruiting NCT05714085 - Efficacy, Safety, and Pharmacokinetics of Vericiguat in Pediatric Participants With Heart Failure Due to Left Ventricular Systolic Dysfunction (MK-1242-036) Phase 2/Phase 3
Completed NCT01086124 - Objective Systolic Function Recuperation Assessed by Echocardiography N/A
Recruiting NCT06270498 - Effect of Oral sucRosomIal Iron on exerciSE Capacity and Quality of Life in Patients With Heart Failure Phase 4
Completed NCT03470155 - Operative Mitral Valve Reconstruction in Functional mv Insufficiency With Reduced Systolic Ventricle Function
Suspended NCT03755570 - How is COGNItive Function Affected by Cardiac Resynchronisation Therapy?
Recruiting NCT04399447 - Multicenter Normal Reference Study of Tissue Motion Tracking of Mitral Annular Displacement(TMAD)
Not yet recruiting NCT03993730 - Cardiovascular Magnetic Resonance GUIDEd Insertion of Implantable Cardiac Defibrillator in Dilated CardioMyopathy N/A
Active, not recruiting NCT01918215 - Cardiac Magnetic Resonance GUIDEd Management of Mild-moderate Left Ventricular Systolic Dysfunction. N/A